Etifoxine is an anxiolytic drug used to treat anxiety disorders. It enhances GABAergic neurotransmission by modulating GABA-A receptors and promoting neurosteroid synthesis. It is grouped under the following drug class(es): Anxiolytics and Psychotropic agents. Its therapeutic use is listed as antianxiety drugs. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Etafenoxine and Etifoxina. Its PubChem CID is 135413553.
Etifoxine
| CAS No | 21715-46-8 |
|---|---|
| Molecular Formula | C17H17Cln2O |
| Molecular Weight | 300.8 g/mol |
| Synonyms | 6-chloro-N-ethyl-4-methyl-4-phenyl-1H-3,1-benzoxazin-2-imine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Etifoxine is an anxiolytic drug used to treat anxiety disorders. It enhances GABAergic neurotransmission by modulating GABA-A receptors and promoting neurosteroid synthesis.
The listed CAS number is 21715-46-8.
The listed molecular formula is C17H17Cln2O.
The listed molecular weight is 300.8 g/mol.
6-chloro-N-ethyl-4-methyl-4-phenyl-1H-3,1-benzoxazin-2-imine.
The source lists Etafenoxine and Etifoxina.